# A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group.

> **NCT06620614** · PHASE1 · COMPLETED · sponsor: **National Academy of Medical Sciences, Nepal** · enrollment: 72 (actual)

## Conditions studied

- Prostatic Hyperplasia, Benign

## Interventions

- **COMBINATION_PRODUCT:** 0.5% Heavy Bupivacaine

## Key facts

- **NCT ID:** NCT06620614
- **Lead sponsor:** National Academy of Medical Sciences, Nepal
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620614, "A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06620614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*